PL2244734T3 - Sposób indukcji tolerancji na alergen - Google Patents

Sposób indukcji tolerancji na alergen

Info

Publication number
PL2244734T3
PL2244734T3 PL09706855T PL09706855T PL2244734T3 PL 2244734 T3 PL2244734 T3 PL 2244734T3 PL 09706855 T PL09706855 T PL 09706855T PL 09706855 T PL09706855 T PL 09706855T PL 2244734 T3 PL2244734 T3 PL 2244734T3
Authority
PL
Poland
Prior art keywords
allergen
inducing tolerance
inducing
tolerance
Prior art date
Application number
PL09706855T
Other languages
English (en)
Inventor
Mimi Lai-Kuan Tang
Original Assignee
Murdoch Childrens Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40913317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2244734(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2008900463A external-priority patent/AU2008900463A0/en
Application filed by Murdoch Childrens Research Institute filed Critical Murdoch Childrens Research Institute
Publication of PL2244734T3 publication Critical patent/PL2244734T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09706855T 2008-02-01 2009-01-30 Sposób indukcji tolerancji na alergen PL2244734T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2008900463A AU2008900463A0 (en) 2008-02-01 A method of inducing tolerance to an allergen

Publications (1)

Publication Number Publication Date
PL2244734T3 true PL2244734T3 (pl) 2017-01-31

Family

ID=40913317

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09706855T PL2244734T3 (pl) 2008-02-01 2009-01-30 Sposób indukcji tolerancji na alergen

Country Status (14)

Country Link
US (5) US9402896B2 (pl)
EP (2) EP2244734B1 (pl)
AU (1) AU2009208390B2 (pl)
CY (1) CY1117948T1 (pl)
DK (1) DK2244734T3 (pl)
ES (2) ES2585407T3 (pl)
HR (1) HRP20160945T1 (pl)
HU (1) HUE029000T2 (pl)
LT (1) LT2244734T (pl)
NZ (1) NZ587137A (pl)
PL (1) PL2244734T3 (pl)
PT (1) PT2244734T (pl)
SI (1) SI2244734T1 (pl)
WO (1) WO2009094717A2 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2244734T (pt) * 2008-02-01 2016-08-05 Murdoch Childrens Res Inst Método para induzir tolerância a um alérgeno
IN2014MN01513A (pl) * 2012-02-07 2015-09-11 Jolla Inst Allergy Immunolog
DE102012101864A1 (de) * 2012-03-06 2013-09-12 Gramme-Revit Gmbh Mittel zur Behandlung von Allergien und anderen Erkrankungen
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
SI3258962T1 (sl) 2015-02-20 2023-07-31 The Board Of Trustees Of The Leland Stanford Junior University Mešane sestave alergenov in postopki za njihovo uporabo
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
MA49791A (fr) 2017-07-18 2020-05-27 Before Brands Inc Procédés de fabrication de compositions d'allergènes mixtes
CN111629721A (zh) 2017-12-06 2020-09-04 百乐吉公司 用于减少过敏反应的组合物和方法
EP3836801A4 (en) * 2018-08-16 2022-05-18 Société des Produits Nestlé S.A. ORAL PEANUT DESENSITIZATION IMMUNOTHERAPY WITH MAINTENANCE DOSE
MX2021008873A (es) 2019-01-23 2021-11-04 Before Brands Inc Métodos para la preparacion de composiciones alergenicas mixtas.
AU2020412960A1 (en) * 2019-12-23 2022-06-16 Prota Therapeutics Pty Ltd Allergy treatment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
AUPQ415899A0 (en) 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases
WO2001066136A2 (en) 2000-04-06 2001-09-13 Panacea Pharmaceuticals, Llc. Microbial delivery system
US7060687B2 (en) 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
EP1364586A1 (en) 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
US20080254058A1 (en) * 2004-12-14 2008-10-16 Alk-Abello A/S Pharmaceutical Composition Comprising a Bacterial Cell Displaying a Heterologous Proteinaceous Compound
US20060233772A1 (en) 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
EP1723965A1 (en) * 2005-05-18 2006-11-22 Stallergenes Sa Compositions for antigen-specific induction of immuno-tolerance via oral immunization
EP1814516B1 (en) * 2005-11-04 2012-12-26 Alk-Abelló A/S Use of a liquid allergy vaccine formulation for oromucosal administration
EP2010645A4 (en) * 2006-04-20 2009-05-06 Univ Singapore RECOMBINANT LACTOBACILLUS AND USE THEREOF
PT2244734T (pt) * 2008-02-01 2016-08-05 Murdoch Childrens Res Inst Método para induzir tolerância a um alérgeno

Also Published As

Publication number Publication date
AU2009208390A1 (en) 2009-08-06
NZ587137A (en) 2013-02-22
ES2950396T3 (es) 2023-10-09
DK2244734T3 (en) 2016-08-15
US20200197515A1 (en) 2020-06-25
EP2244734A2 (en) 2010-11-03
EP2244734B1 (en) 2016-05-04
SI2244734T1 (sl) 2016-11-30
US20190070288A1 (en) 2019-03-07
US9402896B2 (en) 2016-08-02
CY1117948T1 (el) 2017-05-17
US20110097361A1 (en) 2011-04-28
US20230107507A1 (en) 2023-04-06
PT2244734T (pt) 2016-08-05
EP2244734A4 (en) 2012-05-23
AU2009208390B2 (en) 2014-07-17
US20160228542A1 (en) 2016-08-11
US10071157B2 (en) 2018-09-11
EP3097927B1 (en) 2023-05-03
WO2009094717A2 (en) 2009-08-06
HRP20160945T1 (hr) 2016-11-04
LT2244734T (lt) 2016-09-12
HUE029000T2 (en) 2017-02-28
EP3097927A1 (en) 2016-11-30
WO2009094717A3 (en) 2010-10-21
ES2585407T3 (es) 2016-10-05

Similar Documents

Publication Publication Date Title
PL2244734T3 (pl) Sposób indukcji tolerancji na alergen
GB0811942D0 (en) Method of designing a structure
GB2458745B (en) A method of forming an article
PL2376507T3 (pl) Sposób otrzymywania hydroksymetylofosfonianów
AP3169A (en) A method of improved positioning
GB0907924D0 (en) Method of printing
PL2441166T3 (pl) Sposób i układ do eksploatacji turbozespołu w trybie obracania
GB0904571D0 (en) A method of manufacturing a component comprising an internal structure
PL2376347T3 (pl) Sposób montażu łatwo otwieranego zakończenia puszki
EP2351818A4 (en) METHOD FOR STARTING A RECTIFICATION COLUMN
EP2344192A4 (en) METHOD FOR MANUFACTURING A VACCINE
TWI366236B (en) Method of forming power device
EP2256227A4 (en) METHOD FOR REPAIRING AN ELEMENT
GB0810532D0 (en) Method of making an oled
GB0921896D0 (en) A method of manufacturing a component
EP2255187A4 (en) METHOD FOR ASSESSING THE STABILITY OF PROTEINS
PL2440382T3 (pl) Sposób formowania elementu składowego
ZA201105114B (en) Method of manufacturing components
PL385356A1 (pl) Sposób wytwarzania tadalafilu
GB0911416D0 (en) A method of forming an internal structure within a hollow component
GB2489855B (en) A method of forming an article
GB2461497B (en) A method of forming an article
EP2424539A4 (en) PROCESS FOR TREATING DEPRESSION
EP2404891A4 (en) PROCESS FOR THE PREPARATION OF ACYLBENZENES
AU2008900463A0 (en) A method of inducing tolerance to an allergen